Zimbabwe has declined a substantial American health deal worth 367 million US dollars (£272m) over five years over the United States' insistence on sensitive information.
This move was revealed after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government representative later clarified that the United States was requesting genetic material for scientific study and commercial purposes but refused to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further dialogue to secure a deal acceptable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Context
This rejection comes after a similar situation in Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the security of citizens' health data.
After resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and accountability.
According to reports, 16 nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our nation would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our people if a future health crisis arise."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems previously set up through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to deal with future global health emergencies.
"This framework is designed to ensure that when a nation provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to ongoing dialogue with our American counterparts on how future co-operation might be arranged in a manner that respects the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks must proceed since much of the country's HIV programmes relied on foreign aid.
"In cases where specific concerns exist, such as those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group added.
The situation underscores the continuing debate between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.